|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects 显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemother1998，42，8： | 1 |
| 2 | Rivaroxaban( BAY 59-7939) an oral direct factor Xa inhibitor has nolinically relevant interaction with naproxen 显示文摘 | Kubitza D Michaell B Wolfgang M | 2007 | Br J Clin Pharm2007，4，63： | 1 |
| 3 | Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7959 ) in heahhy subjects显示文摘 | Kubitza D Becka M Zuehlsdorf M | 2007 | J Clin Pharmacol2007，47，2： | 1 |
| 4 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | | 0，，： | 1 |
| 5 | Safety, tolerability, phar- macodynamics, and pharmacokinetics of rivaroxaban-an oral, di- rect Factor Xa inhibitor-are not affected by aspirin 显示文摘 | Kubitza D Becka M Mueck W | 2006 | J Clin Pharmacol2006，46，9： | 1 |
| 6 | Metabolism and excretion of rivaroxaban,an oral,direct factor Xa inhibitor,in rats,dogs,and humans显示文摘 | Weinz C Schwarz T Kubitza D | | 0，，： | 1 |
| 7 | Pharmacokinetics of moxifloxacin, a novel 8- methoxy- quinolone, in patients with renal dysfunction显示文摘 | STASS H KUBITZA D HALABI A et ol | 2002 | Br J Clin Pharmacol2002，53，3： | 1 |
| 8 | Formulated diets, feeding strategies, and cannibalism control during intensive culture of juvenile carnivorous fishes 显示文摘 | Kubitza F Lovshin L L | 1999 | Reviews in Fisheries Science1999，7，1： | 1 |
| 9 | No interaction between the novel oral direct factor Xa inhibitor BAY 59-7939 and digoxin 显示文摘 | Kubitza D Mueck W Becka M | 2006 | J Clin Phann2006，46，3： | 1 |
| 10 | Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban-an oral direct factor Xa inhibitor in healthy subjects显示文摘 | Mueck W Beeka M Kubitza D | | 0，，： | 1 |
| 11 | ICAM-1 and VCAM-1 expression following aneurysmal subarach- noid hemorrhage and their possible role in the pathophysi- ology of subsequent ischemic deficits 显示文摘 | Rothoerl RD Schebesch KM Kubitza M | 2006 | Cerebrovasc Dis2006，22，23： | 1 |
| 12 | Preclinical and clinical characteristics of rivarraxaban:a novel,oral,direct factor Xa inhibitor显示文摘 | Laux V Perzborn E Kubitza D | | 0，，： | 1 |
| 13 | Pharmacokinetics, safety,and tolerbility of ascending single doses of Moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | Antimicrob Agents Chemothe1998，42，8： | 1 |
| 14 | Pharmacokinetics, safety, and tolerability of ascending singledoses of moxifloxacin, a new 8-rnethoxyquinolone, administered to healthy subjects显示文摘 | Stass H Dalhoff A Kubitza D | 1998 | 42(8): 2060-20651998，42，8： | 1 |
| 15 | Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects 显示文摘 | Kubitza D Becka M Zuehlsdorf M | 2007 | J Clin Pharmacol2007，47，2： | 1 |
| 16 | Formulated diets, feeding strategies, and cannibalism control dur/ng intensive culture of juvenile carnivorous fishes 显示文摘 | Kubitza F Lovshin L L | 1999 | Rev Fish Sci1999，7，1： | 1 |
| 17 | A woman with postoperative hyponatremia related to desmopressin acetate显示文摘 | Adrian Schreiber Sebastian Kubitza Friedrich C Luft | 2004 | American Journal of Kidney Diseases2004，44，1： | 1 |
| 18 | ICAM-1 andVCAM-1expression following aneurysmal subarachniod hemorrhageand their possible role in the pathopysiology of subsequent ischmicdeficits显示文摘 | Rothoer RD Schebesch KM Kubitza M | 2006 | Cerebrovasc Dis2006，22，23： | 1 |
| 19 | Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man显示文摘 | Stass H Kubitza D | 1999 | J Antimicrob Chemother1999，43，： | 1 |
| 20 | Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man 显示文摘 | Stass H Kubitza 13 | 1999 | J Antimicrob Chemoth1999，43，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员